Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182716![]() (US9145402, 23 | US9145402, 36) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182713![]() (US9145402, 20) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM60652![]() (US9145402, 1) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM60653![]() (US9145402, 2) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182715![]() (US9145402, 22) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182712![]() (US9145402, 19) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182716![]() (US9145402, 23 | US9145402, 36) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182728![]() (US9145402, 35) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182727![]() (US9145402, 34) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182726![]() (US9145402, 33) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182724![]() (US9145402, 31) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182723![]() (US9145402, 30) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182731![]() (US9145402, 38) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM50398665![]() (CHEMBL2178137 | US9145402, 15) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | CHEMBL PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182703![]() (US9145402, 9) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182714![]() (US9145402, 21) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182725![]() (US9145402, 32) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182718![]() (US9145402, 25) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | Purchase PC cid PC sid UniChem Similars | US Patent | 7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182701![]() (US9145402, 7) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182702![]() (US9145402, 8) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM60657![]() (US9145402, 5) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM60656![]() (US9145402, 4) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182708![]() (US9145402, 14) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182717![]() (US9145402, 24) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182711![]() (US9145402, 18) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182710![]() (US9145402, 17) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182707![]() (US9145402, 13) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182706![]() (US9145402, 12) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182709![]() (US9145402, 16) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM60654![]() (US9145402, 3) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182720![]() (US9145402, 27) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182705![]() (US9145402, 11) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 27 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182721![]() (US9145402, 28) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 35 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182722![]() (US9145402, 29) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | Purchase PC cid PC sid UniChem Similars | US Patent | 36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182704![]() (US9145402, 10) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 46 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182719![]() (US9145402, 26) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 47 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182730![]() (US9145402, 37) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem Similars | US Patent | 56 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Leucine-rich repeat serine/threonine-protein kinase 2 (LRRK2) (Homo sapiens (Human)) | BDBM182700![]() (US9145402, 6) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | PC cid PC sid UniChem | US Patent | 61 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description his assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining, Kiapp, IC50, or percent inhibition values. In 38... | US Patent US9145402 (2015) BindingDB Entry DOI: 10.7270/Q2J67FQ3 | |||||||||||
More data for this Ligand-Target Pair |